titration side-effects symptoms
The first months of GLP-1 treatment are where most users quit.
Steadiva focuses on one principle during titration: context beats raw symptoms.
Instead of “I felt nauseous,” we track:
- dose and dose change week,
- injection site,
- symptom severity (1-4),
- timing after injection.
That combination allows meaningful review:
- Did nausea spike only after a dose increase?
- Is one site consistently better tolerated?
- Are symptoms settling after week two?
This is the exact level of detail a clinician can act on during a real follow-up.